Models of Pulmonary Infections

Investigation of pulmonary fungal infections in immunocompromised patients

Background: With increasing immunocompromised patients, fungal infections especially lung infection, have also increased. In this study, fungal contamination of the respiratory system in immunocompromised patients was evaluated. Methods: This descriptive cross-sectional study was conducted in immunocompromised patients suspicious of pulmonary infections referring to specialized lung clinic of ...

Pulmonary Infections

Infections in the respiratory tract are very common but majority involve the upper respiratory system. Pneumonia is usually caused by inhalation of infecting organisms or the same may reach the lung via bloodstream. Pulmonary pathogens can cause tissue damage by a direct invasive cytolytic process or by releasing toxins (endotoxins and/or exotoxins). Acute inflammation may lead to complete reso...

Imaging of Pulmonary Infections

Pulmonary fungal infections.

This review details some of the advances that have been made in the recent decade in the diagnosis, treatment and epidemiology of pulmonary fungal infections. These advances have occurred because of increasing knowledge regarding the fungal genome, better understanding of the structures of the fungal cell wall and cell membrane and the use of molecular epidemiological techniques. The clinical i...

Phage therapy of pulmonary infections

It is generally agreed that a bacteriophage-associated phenomenon was first unambiguously observed one-hundred years ago with the findings of Twort in 1915. This was independently followed by complementary observations by d'Hérelle in 1917. D'Hérelle's appreciation of the bacteriophage phenomenon appears to have directly led to the development of phages as antibacterial agents within a variety ...